Ignite Creation Date:
2024-05-06 @ 7:04 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05886049
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2023-06-01
Brief Title:
Testing the Addition of an Anti-cancer Drug SNDX-5613 to the Standard Chemotherapy Treatment Daunorubicin and Cytarabine for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLLKMT2A Gene
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-01
First Submit QC Date:
June 1 2023
Study First Post Date:
2023-06-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-06-25
Last Update Post Date Type:
ACTUAL